We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

600688:SSESinopec Shanghai Petrochemical Co. Ltd. Class A Analysis

Data as of 2026-03-15 - not real-time

CN¥3.26

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Technical outlook: The 20‑day SMA sits above the 50‑day and 200‑day SMAs, suggesting a short‑term bullish bias, while the price of CNY 3.26 trades above the identified support around CNY 3.03 and below the resistance near CNY 3.89. RSI hovers around the neutral 50 level and the MACD histogram has turned negative, hinting at a potential near‑term pull‑back. Volume is rising and beta is essentially flat, meaning price moves are largely idiosyncratic, but volatility remains elevated at roughly 60% over the past month.
Fundamental outlook: Revenue has contracted by roughly 14% year‑over‑year and margins are thin to negative, with trailing EPS still in the red. A forward P/E of about 80× dwarfs the industry average of 22×, indicating the stock is materially overvalued relative to peers. Dividend yield is modest at 0.6% and, given the negative earnings and cash‑flow profile, the payout appears unsustainable despite a solid cash balance that outweighs debt. Overall, the blend of weak earnings, lofty valuation multiples, and high price volatility points to heightened downside risk.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 5/10

Key Factors

  • Bullish SMA crossover supports limited upside
  • MACD bearish divergence suggests near‑term weakness
  • Elevated volatility raises short‑term price swing risk

Medium Term

1–3 years
Cautious
Model confidence: 7/10

Key Factors

  • Overvalued forward P/E relative to industry
  • Negative earnings and cash‑flow trends
  • Uncertain dividend sustainability

Long Term

> 3 years
Neutral
Model confidence: 4/10

Key Factors

  • Potential recovery in petrochemical demand
  • Strong net cash position offsets debt load
  • Regulatory and environmental headwinds remain

Key Metrics & Analysis

Financial Health

Revenue Growth-13.80%
Profit Margin-0.19%
P/E Ratio81.5
ROE-0.60%
ROA-0.47%
Debt/Equity2.27
P/B Ratio1.4
Op. Cash FlowCN¥-18232000
Free Cash FlowCN¥-2185614592
Industry P/E22.2

Technical Analysis

TrendBullish
RSI49.2
SupportCN¥3.03
ResistanceCN¥3.89
MA 20CN¥3.33
MA 50CN¥3.10
MA 200CN¥2.89
MACDBearish
VolumeIncreasing
Fear & Greed Index72.88

Valuation

GradeOvervalued
TypeValue
Dividend Yield0.61%

Risk Assessment

Beta-0.04
Volatility60.03%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.